Cargando…
Drug Delivery Strategies for the Treatment of Pancreatic Cancer
Pancreatic cancer is fast becoming a global menace and it is projected to be the second leading cause of cancer-related death by 2030. Pancreatic adenocarcinomas, which develop in the pancreas’ exocrine region, are the predominant type of pancreatic cancer, representing about 95% of total pancreatic...
Autores principales: | Olajubutu, Oluwabukunmi, Ogundipe, Omotola D., Adebayo, Amusa, Adesina, Simeon K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222836/ https://www.ncbi.nlm.nih.gov/pubmed/37242560 http://dx.doi.org/10.3390/pharmaceutics15051318 |
Ejemplares similares
-
Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives
por: Adebayo, Amusa S., et al.
Publicado: (2023) -
Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect
por: Ejigah, Victor, et al.
Publicado: (2022) -
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
por: Viegas, Cláudia, et al.
Publicado: (2023) -
Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery
por: Liu, Xiangsheng, et al.
Publicado: (2019) -
Advanced drug delivery and therapeutic strategies for tuberculosis treatment
por: Nair, Ayushi, et al.
Publicado: (2023)